Research Keyword: calcineurin signaling

Recent innovations and challenges in the treatment of fungal infections

mycolabadmin

Fungal infections are becoming more common and dangerous, especially for people with weakened immune systems, and many fungi are developing resistance to current medications. Doctors and researchers are developing new treatment strategies, including combining multiple drugs together and using advanced technologies to deliver medicines more effectively to infected areas. Natural compounds from plants and new biotechnology tools like genetic engineering and nanoparticles show promising results for fighting drug-resistant fungal infections.

Read More »

Recent innovations and challenges in the treatment of fungal infections

mycolabadmin

Fungal infections are becoming more common and harder to treat due to drug resistance, especially in people with weakened immune systems. Current antifungal medications are becoming less effective because fungi are adapting to resist them, and these drugs can cause serious side effects. Scientists are developing new treatment strategies using combinations of existing drugs, engineered biological approaches, and specially designed delivery systems to overcome resistance and improve patient outcomes.

Read More »

The cyclase-associated protein contributes to antifungal susceptibility and virulence in Aspergillus fumigatus

mycolabadmin

Researchers found that removing a specific protein called CAP from a dangerous mold called Aspergillus fumigatus makes it much weaker and easier to kill with antifungal drugs. This mold normally causes serious lung infections in people with weak immune systems. The study showed that CAP helps the mold grow and resist medicines, and blocking it could be a new way to treat these dangerous infections.

Read More »
Scroll to Top